Science Fair Project Encyclopedia
Leslie Dan
Leslie Lewis Dan (born November 26, 1929) is a Canadian businessman and philanthropist.
Born in Budapest, Dan can to Canada after World War II in 1947. He survived during the war by using false identity papers. He graduated with a BSc from the University of Toronto School of Pharmacy in 1954. He completed his MBA in 1959. In 1960, he started a company which distributed over-the-counter drugs.
In 1965 he started Novopharm . When he sold the company in 2000, to Israel's Teva Pharmaceuticals for an estimated $430 million, it had sales of $750 million and it employed 3,000 people. He then started a new company, Viventia [formerly Novopharm Biotech], which specializes in the discovery and development of products for the treatment of cancer. He currently is the Chairman.
In 2003, he had an estimated net worth of $1.26 billion.
A notable philanthropist, some of his donations and honours include:
- He donated $15 million to the University of Toronto.
- The University of Toronto Leslie Dan Faculty of Pharmacy is named in his honour.
- The new University of Toronto Leslie L. Dan Pharmacy Building, designed by Sir Norman Foster and to be completed in 2005, is named in his honour.
- He founded the Canadian Medicine Aid Programme (CAN-MAP) in 1985, an organization which provides life saving medicines and other aid to the sick in the Third World.
- In 1996 he was made a Member of the Order of Canada and awarded the Order of Ontario.
- He received an honorary Doctorate of Laws Degree from Dalhousie University in 1996 and the University of British Columbia in 1995.
- In 1997 he received the Distinguished Business Alumnus Award by the University of Toronto Joseph L. Rotman Faculty of Management.
- The Aish HaTorah's Dan Family Building is named in his honour.
- He has donated to Yad Vashem.
He married Judith in 1958. She died in 1995. They had a son Aubrey. He remarried Anna in 1996.
The contents of this article is licensed from www.wikipedia.org under the GNU Free Documentation License. Click here to see the transparent copy and copyright details


